Product Information
ATIVAN 0.5 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $35.3423 per EA under NDC 00187006301. Its NADAC has been published 539 times since May 14, 2014.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lorazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/1
Manufacturer
Bausch Health US LLCNDC
00187006301
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA017794FDA Approved
Before 1982
TE Code
AB
On Market Since
5/1/2013
Pharmacological Classes
Price Statistics
The NADAC for ATIVAN 0.5 MG TABLET has been published 539 times since May 14, 2014, and over the history we have for it it has risen 473.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $35.3423 per EA |
|---|---|
| All-time high | $35.4363 (May 14, 2025) |
| All-time low | $6.1622 (May 14, 2014) |
| Median price | $25.5885 |
| Average price | $24.5943 |
| Largest weekly change | +76.0% (Jan 7, 2015) |
| Weeks tracked | 539 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+10.9%
5Y
+28.0%
All
+473.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lorazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lorazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATIVAN 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATIVAN 0.5 MG TABLET, manufactured by Bausch Health US LLC, is $35.3423 per EA (NDC 00187006301), effective Oct 1, 2025.
How has the price of ATIVAN 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATIVAN 0.5 MG TABLET has risen 473.5%. It has been tracked across 539 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for ATIVAN 0.5 MG TABLET?
Since May 14, 2014, the NADAC for ATIVAN 0.5 MG TABLET has ranged from a low of $6.1622 (May 14, 2014) to a high of $35.4363 (May 14, 2025), with a median of $25.5885 per EA.
Are there cheaper alternatives to ATIVAN 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ATIVAN 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ATIVAN 0.5 MG TABLET?
ATIVAN 0.5 MG TABLET (NDC 00187006301) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.